Efficacy of amodiaquine, sulphadoxine-pyrimethamine and their combination for the treatment of uncomplicated Plasmodium falciparum malaria in children in …
WF Mbacham, MSB Evehe, PM Netongo, IA Ateh… - Malaria journal, 2010 - Springer
Background The efficacy of amodiaquine (AQ), sulphadoxine-pyrimethamine (SP) and the
combination of SP+ AQ in the treatment of Cameroonian children with clinical malaria was …
combination of SP+ AQ in the treatment of Cameroonian children with clinical malaria was …
[HTML][HTML] Targeted deep amplicon sequencing of antimalarial resistance markers in Plasmodium falciparum isolates from Cameroon
M L'Episcopia, J Kelley, BGD Dongho, D Patel… - International Journal of …, 2021 - Elsevier
Background Recent studies showed the first emergence of the R561H artemisinin-
associated resistance marker in Africa, which highlights the importance of continued …
associated resistance marker in Africa, which highlights the importance of continued …
Effects of Drug Policy Changes on Evolution of Molecular Markers of Plasmodium falciparum Resistance to Chloroquine, Amodiaquine, and Sulphadoxine …
Background. As a result of the spread of parasites resistant to antimalarial drugs, Malaria
treatment guidelines in Cameroon evolved from nonartemisinin monotherapy to artemisinin …
treatment guidelines in Cameroon evolved from nonartemisinin monotherapy to artemisinin …
In Vivo Efficacy of Artesunate/Sulphadoxine-Pyrimethamine versus Artesunate/Amodiaquine in the Treatment of Uncomplicated P. falciparium Malaria in Children …
TO Apinjoh, JK Anchang-Kimbi, MU Ajonina… - Biomedicines, 2016 - mdpi.com
Background: The development and spread of antimalarial drug resistant parasites
contributes to the global impact of the disease. In vivo efficacy assessments of treatments for …
contributes to the global impact of the disease. In vivo efficacy assessments of treatments for …
Current status of 4-aminoquinoline resistance markers 18 years after cessation of chloroquine use for the treatment of uncomplicated falciparum malaria in the littoral …
MN Moyeh, SN Fankem, IM Ali, D Sofeu… - … and Global Health, 2022 - Taylor & Francis
The onset and rapid spread of chloroquine resistance and the introduction of amodiaquine
for the treatment of uncomplicated malaria in Cameroon have influenced the proportion of …
for the treatment of uncomplicated malaria in Cameroon have influenced the proportion of …
Antimalarial Drug Resistance: Clinical Perspectives
B Pradines - … Drug Resistance: Clinical and Epidemiological Aspects …, 2017 - Springer
Despite efforts to discover new antiplasmodial drugs and to accomplish effective
implementation of therapeutic combinations for malaria treatment by health systems, P …
implementation of therapeutic combinations for malaria treatment by health systems, P …
Efficacy and Safety of Artemether-Lumefantrine, Artesunate-mefloquine Vs Dihydroartemisinin-piperaquine in the Treatment of P. Falciparum Malaria in Cameroon
TN Metoh, R Moyou-Somo, P Fon-Gah, X Zhou… - 2021 - researchsquare.com
Background: Artemisinin-based Combination Therapies (ACTs), have been reported to be
effective against multidrug-resistant Plasmodium falciparum. There are controversies in the …
effective against multidrug-resistant Plasmodium falciparum. There are controversies in the …
[PDF][PDF] Research Article Effects of Drug Policy Changes on Evolution of Molecular Markers of Plasmodium falciparum Resistance to Chloroquine, Amodiaquine, and …
Background. As a result of the spread of parasites resistant to antimalarial drugs, Malaria
treatment guidelines in Cameroon evolved from nonartemisinin monotherapy to artemisinin …
treatment guidelines in Cameroon evolved from nonartemisinin monotherapy to artemisinin …
[PDF][PDF] Wilfred F Mbacham1, 2, Marie-Solange B Evehe1, Palmer M Netongo1, Isabel A Ateh1, Patrice N Mimche1, Anthony Ajua1, Akindeh M Nji1, Domkam Irenee1 …
C Roper, G Targett, B Greenwood - 2010 - malariajournal.biomedcentral.com
Background: The efficacy of amodiaquine (AQ), sulphadoxine-pyrimethamine (SP) and the
combination of SP+ AQ in the treatment of Cameroonian children with clinical malaria was …
combination of SP+ AQ in the treatment of Cameroonian children with clinical malaria was …
Evaluation de la chimiorésistance à la sulfadoxine-pyrimethamine et des mutations des gènes dihydrofolate réductase et dihydropteroate synthétase dans le district …
NEN Nfor, WF Mbacham, N Njikam, IA Mbulli… - African Journal of …, 2007 - ajol.info
Les données cliniques sur la résistance au sulfadoxine-pyriméthamine (SP) sont peu
précises dans plusieurs localités du Cameroun. En plus, très peu d'informations sont …
précises dans plusieurs localités du Cameroun. En plus, très peu d'informations sont …